Vimarsana
Biggest News Aggregation in the World

Doris Yiu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doris Yiu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doris Yiu Today - Breaking & Trending Today

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership - Vimarsana News

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , a global leader in generic and innovative medicines and Alvotech , a global biotech company specializing in the...

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-D - Vimarsana News

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-D

New once-daily AUSTEDO XR regimen now approved in 6, 12, and 24 mg tablet strengthsAUSTEDO is the only vesicular monoamine transporter 2 (VMAT2) inhibitor approved for both tardive dyskinesia (TD) and chorea associated with Huntington’s disease (HD) indications1,2AUSTEDO is the only VMAT2 inhibitor with 3-year long-...

Teva Pharmaceutical Industries Limited: Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir Digihaler (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022 - Vimarsana News

Teva Pharmaceutical Industries Limited: Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir Digihaler (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022

The study evaluated the effect of the ProAir Digihaler System on asthma control versus standard of care as measured by the Asthma Control Test, and explored use of the ProAir Digihaler System to help

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute - Vimarsana News

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Branded Pharmaceutical Products R&D, Inc. and Auspex Pharmaceuticals, Inc., U.S. affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), have reached an agreement with Aurobindo to resolve the dispute over Aurobindo’s Abbreviated New Dru...

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget - Vimarsana News

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget News provided by Share this article Share this article TORONTO, April 20, 2021 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., strongly welcomes the Government of Canada's commitment in the April 19, 2021 federal budget to support Canada's life science sector. The Budget includes $2.2 billion over seven years "towards growing a vibrant domestic life sciences sector" and will be part of the plan "to build domestic resilience and improve long-term pandemic preparedness". Christin...